Determination of enantiomerization barriers of desloratadine and its N-oxide derivative by dynamic enantioselective high-performance liquid chromatography and off-column racemization experiments
Francesca Romana Mammone , Simone Manetto , Giulia Mazzoccanti , Daniele Sadutto , Marco Pierini , Roberto Cirilli
{"title":"Determination of enantiomerization barriers of desloratadine and its N-oxide derivative by dynamic enantioselective high-performance liquid chromatography and off-column racemization experiments","authors":"Francesca Romana Mammone , Simone Manetto , Giulia Mazzoccanti , Daniele Sadutto , Marco Pierini , Roberto Cirilli","doi":"10.1016/j.jpba.2025.117159","DOIUrl":null,"url":null,"abstract":"<div><div>Desloratadine, a tricyclic histamine H<sub>1</sub>-receptor antagonist, is employed in the treatment of asthma and other allergic conditions. Its efficacy against various types of tumors has also been demonstrated. The molecule possesses a non-planar central seven-membered ring, devoid of a plane of symmetry, which confers planar stereogenicity. In this study, the energy barriers for the inversion of the p<em>R</em> and p<em>S</em> enantiomers, which occurs via a near-planar transition state, have been determined by on-column dynamic high-performance liquid chromatography and parallel kinetic off-column experiments based on electronic circular dichroism measurements. The kinetic and thermodynamic data pertinent to enantiomerization process were compared with those obtained for the N-oxide derivative of desloratadine. The results indicated that the targeted oxidation increased the activation enantiomerization barriers, thus conferring configurational stability to enantiomers. To complete the work, the absolute configuration of the enantiomers of the N-oxide derivative of desloratadine was established by comparing their experimental and theoretical chiroptical properties.</div></div>","PeriodicalId":16685,"journal":{"name":"Journal of pharmaceutical and biomedical analysis","volume":"267 ","pages":"Article 117159"},"PeriodicalIF":3.1000,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of pharmaceutical and biomedical analysis","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S073170852500500X","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, ANALYTICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Desloratadine, a tricyclic histamine H1-receptor antagonist, is employed in the treatment of asthma and other allergic conditions. Its efficacy against various types of tumors has also been demonstrated. The molecule possesses a non-planar central seven-membered ring, devoid of a plane of symmetry, which confers planar stereogenicity. In this study, the energy barriers for the inversion of the pR and pS enantiomers, which occurs via a near-planar transition state, have been determined by on-column dynamic high-performance liquid chromatography and parallel kinetic off-column experiments based on electronic circular dichroism measurements. The kinetic and thermodynamic data pertinent to enantiomerization process were compared with those obtained for the N-oxide derivative of desloratadine. The results indicated that the targeted oxidation increased the activation enantiomerization barriers, thus conferring configurational stability to enantiomers. To complete the work, the absolute configuration of the enantiomers of the N-oxide derivative of desloratadine was established by comparing their experimental and theoretical chiroptical properties.
期刊介绍:
This journal is an international medium directed towards the needs of academic, clinical, government and industrial analysis by publishing original research reports and critical reviews on pharmaceutical and biomedical analysis. It covers the interdisciplinary aspects of analysis in the pharmaceutical, biomedical and clinical sciences, including developments in analytical methodology, instrumentation, computation and interpretation. Submissions on novel applications focusing on drug purity and stability studies, pharmacokinetics, therapeutic monitoring, metabolic profiling; drug-related aspects of analytical biochemistry and forensic toxicology; quality assurance in the pharmaceutical industry are also welcome.
Studies from areas of well established and poorly selective methods, such as UV-VIS spectrophotometry (including derivative and multi-wavelength measurements), basic electroanalytical (potentiometric, polarographic and voltammetric) methods, fluorimetry, flow-injection analysis, etc. are accepted for publication in exceptional cases only, if a unique and substantial advantage over presently known systems is demonstrated. The same applies to the assay of simple drug formulations by any kind of methods and the determination of drugs in biological samples based merely on spiked samples. Drug purity/stability studies should contain information on the structure elucidation of the impurities/degradants.